Mutations in BAP1 can cause various types of cancer, such as renal cell carcinoma and mesothelioma, and when BAP1 is mutated, the inhibition of SLC7A11 and the promotion of ferroptosis are lost (Zhang et al., 2018b). Here, BAP1 is linked to hereditary clear cell renal cell carcinoma.